Philips on Monday said it will halt the sales of new sleep-therapy devices in the U.S., as part of a broader settlement that led the company to take a €363.
By Elena Vardon Royal Philips is scheduled to report results for its fourth quarter and 2023 on Monday. Here is what you need to know: SALES FORECAST: The.
Shares of technology companies fell as traders rotated out of some of the fastest rising AI companies. Palantir Technologies fell sharply after analysts at.
Phillips shares fell sharply Wednesday as the Food and Drug Administration said there's an emerging safety issue involving its product for sleep apnea.